Respiratory viruses are the most common cause of sickness in humans, with considerable morbidity and mortality rates around the world. Community-based investigations undertaken over the last five decades or so demonstrate that common respiratory agents from several virus families are the primary etiological agents of acute respiratory infections (ARIs). The severity of viral respiratory illness varies, but it is more common in elderly people and new-borns. Despite the fact that respiratory viruses cause a wide variety of diseases, there are now just a few preventive or therapeutic strategies available. Recent discoveries in respiratory virus molecular and cell biology, on the other hand, should lead to the development of helpful therapies.
Title : Dengue transmission and Aedes vector dynamics before, during and after COVID-19 travel restrictions
Ranjan Ramasamy, IDFISH Technology and University of Jaffna, United States
Title : Viral RNA structures as regulators of gene expression and therapeutic targets
Silvi Rouskin, Harvard Medical School, United States
Title : Novel functions of IRF3 in viral infection and inflammation
Saurabh Chattopadhyay, The University of Toledo, United States
Title : Therapeutic intervention of Bunyavirus induced hemorrhagic fever and cardiopulmonary disease
Mohammad Mir, Western University of Health Sciences, United States
Title : Why and how we discover and study the biology of viruses of micro-organisms in Aotearoa New Zealand
Robin Mac Diarmid, University of Auckland, New Zealand
Title : Antiviral action of aqueous extracts of propolis from scaptotrigona aff. postica against zica, chikungunya, and mayaro virus
Zucatelli, Instituto Butantan, Brazil